Identification of NRAS Diagnostic Biomarkers and Drug Targets for Endometrial Cancer—An Integrated in Silico Approach

The diagnosis of endometrial cancer involves sequential, invasive tests to assess the thickness of the endometrium by a transvaginal ultrasound scan. In 6–33% of cases, endometrial biopsy results in inadequate tissue for a conclusive pathological diagnosis and 6% of postmenopausal women with non-dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Alessandro, Larsen, Low, Kat-Jun Eric, Abushelaibi, Aisha, Lim, Swee-Hua Erin, Cheng, Wan-Hee, Chang, Sook-keng, Lai, Kok-Song, Sum, Yap Wai, Maran, Sathiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692821/
https://www.ncbi.nlm.nih.gov/pubmed/36430761
http://dx.doi.org/10.3390/ijms232214285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692821/
https://www.ncbi.nlm.nih.gov/pubmed/36430761
http://dx.doi.org/10.3390/ijms232214285

Ejemplares similares